Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology…
Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
divestment
Glenmark to divest majority stake in Glenmark Life Sciences to Nirma
Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share
GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores
The transaction is expected to be completed by September 30, 2021
Dr Reddy’s to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries
The acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine.